Deciphera Pharmaceuticals Inc (DCPH)

Deciphera Pharmaceuticals Inc Azioni (DCPH) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	11.50% 48.29	43.31	38.30	33.45	36.34
Cost Of Revenue	38.80% 1.785	1.286	0.173	0.488	3.245
Gross Profit	10.66% 46.51	42.03	38.13	32.96	33.10
Operating Expenses	2.12% 97.75	95.72	90.91	86.21	80.26
Benefits Costs and Expenses	14.35% 83.08	97.00	91.08	86.70	78.99
Costs And Expenses	2.61% 99.53	97.00	91.08	86.70	83.51
Operating Income/Loss	4.56% -51.24	-53.69	-52.77	-53.26	-47.16
Nonoperating Income/Loss	9.06% 4.479	4.107	4.213	3.648	1.948
Income/Loss From Continuing Operations Before Tax	35.20% -34.79	-53.69	-52.77	-178.90	-42.65
Income/Loss From Continuing Operations After Tax	4.82% -47.19	-49.58	-48.56	-178.90	-45.94
Net Income/Loss	4.82% -47.19	-49.58	-48.56	-178.90	-45.94
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.35% 0.5534	85.79	85.02	82.68	2.3703
Diluted Average Shares	99.35% 0.5534	85.79	85.02	82.68	2.3703
Basic Earnings Per Share	6.90% -0.54	-0.58	-0.57	-0.60	-0.55
Diluted Earnings Per Share	6.90% -0.54	-0.58	-0.57	-0.60	-0.55
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-